MRD / Regn No. : THBC\23-24\04576 Date : 21/07/2026
Patient Name : Amol Potphode Age & Gender : 52 Yrs. / Male
Contact No. : 9930733474 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (10/Jul/2011) | HTN (10/Jul/2011) | DYSLIPIDEMIA (10/Jul/2021) |
Subjective : T2DM SINCE 2011,HTN- 2011,DYSLIPIDEMIA SINCE 2021,F/H OF DM - MOM/CABG,ADD PROTEIN SUPPLEMENT
Objective : 18-JUL-2026 REPORTS,HBA1C-6.90%,ACR-50.24
Plan : STOP EMPAGLIFLOZIN AS DOES NOT TOLERATE,RECHECK URINE ALBUMIN:CREAT RATIO AFTER 30 DAYS - IF ELEVATED - START KERENDIA 10 MG,CHECK POTASSIUM / SERUM CREATININE AFTER 2 WEEKS OF ADDING KERENDIA,IF NORMAL - REPEAT URINE ALBUMIN:CREAT RATIO IN NEXT VISIT  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET VILDAGLIPTIN (50MG) AND METFORMIN (1000MG)
GALVUS MET 50/1000
Medicine For DIABETES
ORAL 1-0-1 BBF / BD
3 MTHS
2 TABLET ROSUVASTATIN + ASPIRIN
ROZUCOR ASP
ORAL 0-0-1 AD
3 MTHS
3 TELMA AM 80/5 ORAL 1-0-0 ABF
3 MTHS
4 TABLET ACARBOSE 25MG
GLUCOBAY 25 MG
ORAL 0-1-0 WL
3 MTHS
5 KERENDIA 10 MG ORAL 1-0-0 ABF
3 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 12/May/2026
Tests Suggested For Next Visit : AFTER 3 MTHS - FBS / PPBS / HBA1C / URINE FOR ALBUMIN:CREAT RATIO,SERUM CREATININE / SERUM POTASSIUM 14 DAYS AFTER STARTING KERENDIA
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: